Recently conducted analyses indicate that ubiquitin plays a pivotal part in multiple signaling and cell regulatory events in malignancies, including but not limited to gynecological [47] and breast cancer, which remain the most common carcinoma and second cause of premature death amongst women globally [48,49]. This evidence concerns the gene UBA52 and breast carcinoma.